全文获取类型
收费全文 | 1104篇 |
免费 | 65篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 48篇 |
妇产科学 | 27篇 |
基础医学 | 116篇 |
口腔科学 | 24篇 |
临床医学 | 149篇 |
内科学 | 221篇 |
皮肤病学 | 7篇 |
神经病学 | 78篇 |
特种医学 | 145篇 |
外科学 | 124篇 |
综合类 | 16篇 |
一般理论 | 1篇 |
预防医学 | 78篇 |
眼科学 | 3篇 |
药学 | 109篇 |
中国医学 | 1篇 |
肿瘤学 | 29篇 |
出版年
2021年 | 18篇 |
2020年 | 15篇 |
2019年 | 33篇 |
2018年 | 23篇 |
2017年 | 13篇 |
2016年 | 10篇 |
2015年 | 21篇 |
2014年 | 20篇 |
2013年 | 37篇 |
2012年 | 44篇 |
2011年 | 55篇 |
2010年 | 30篇 |
2009年 | 29篇 |
2008年 | 39篇 |
2007年 | 39篇 |
2006年 | 31篇 |
2005年 | 29篇 |
2004年 | 26篇 |
2003年 | 29篇 |
2002年 | 21篇 |
2001年 | 25篇 |
2000年 | 23篇 |
1999年 | 23篇 |
1998年 | 24篇 |
1997年 | 26篇 |
1996年 | 31篇 |
1995年 | 16篇 |
1994年 | 21篇 |
1993年 | 11篇 |
1992年 | 19篇 |
1991年 | 14篇 |
1990年 | 18篇 |
1989年 | 25篇 |
1988年 | 28篇 |
1987年 | 20篇 |
1986年 | 18篇 |
1985年 | 30篇 |
1983年 | 27篇 |
1982年 | 21篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1978年 | 12篇 |
1977年 | 15篇 |
1976年 | 16篇 |
1975年 | 13篇 |
1974年 | 15篇 |
1973年 | 10篇 |
1972年 | 12篇 |
1971年 | 10篇 |
1970年 | 16篇 |
排序方式: 共有1184条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A). 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Antimicrobial agents and chemotherapy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
R W Sidwell J H Huffman E W Call R P Warren L A Radov R J Murray 《Antimicrobial agents and chemotherapy》1987,31(7):1130-1134
PR-879-317A (2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo [1,2a]pyridine) has been found to be a T-cell-selective immunomodulating agent. In the current studies, a series of experiments was designed to determine the potential antiviral activity of this compound in mice infected with murine hepatitis virus. In a comparative antiviral experiment, the activity seen was superior to that of levamisole, a known immunorestorative agent. This activity was characterized by an increase in the 21-day survival frequency, a decrease in hepatic discoloration, a decrease in the amount of infectious virus recoverable from the liver, and normalization of serum glutamic oxalacetate and pyruvate transaminase levels. A comparison of treatment routes indicated the relative efficacies as intraperitoneal greater than per os greater than intramuscular greater than or equal to subcutaneous. Alteration of the treatment schedule markedly affected the antiviral effect; prophylactic or therapeutic treatments once or twice daily for 3 days were usually effective. Single treatments begun 4 h before or 24 h after virus inoculation were highly efficacious. Three treatments administered on alternate days, beginning 48 h before virus inoculation, proved moderately effective. Thrice-daily treatments were ineffective, as were treatments with durations of greater than 3 days. The optimal dosage varied according to the treatment route and dosage schedule. When assessed for direct antiviral activity in vitro, PR-879-317A failed to demonstrate any significant activity against murine hepatitis virus. The positive in vivo activity noted might therefore be the result of immune modulation rather than a direct antiviral effect. 相似文献
5.
Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results 总被引:3,自引:0,他引:3
Mattrey RF; Strich G; Shelton RE; Gosink BB; Leopold GR; Lee T; Forsythe J 《Radiology》1987,163(2):339-343
In animals, perfluorochemicals (PFCs) are effective ultrasound (US) contrast agents that produce hepatic, splenic, and tumor enhancement. The use of Fluosol-DA 20%, an emulsion of perfluorodecalin and perfluorotripropylamine, was studied in nine non-critically ill patients with cancer who had liver lesions. US studies without Fluosol were compared with studies obtained 24, 48, and 72 hours after Fluosol infusion. Vital signs and extensive laboratory analyses are performed before and after Fluosol infusion. Liver metastases from colonic, pancreatic, and gastric carcinoma exhibited rim or diffuse enhancement after a Fluosol dose of 1.6 g/kg or greater. Fluosol produced echogenic enhancement of the liver and spleen relative to kidney at a dose of 2.4 g/kg, allowing the detection of nonenhancing lesions. In addition, Fluosol at a dose of 1.6 g/kg or greater allowed detection of lesions not seen before contrast medium was administered in three of the seven patients studied. There was a mild increase in the level of serum glutamic oxaloacetic transaminase in two patients, one given 2.4 and the other 3.2 g/kg of Fluosol. Mild and transient allergic reactions without change in vital signs were experienced by two patients. 相似文献
6.
7.
8.
9.
L M Huffman 《AANA journal》1989,57(2):142-152
Until recently, there had been no simple, accurate, and reliable technique for monitoring depth of anesthesia, but now a monitoring system that measures lower esophageal contractility (LEC) is available. The system consists of a monitor and a disposable esophageal stethoscope equipped with provoking and measuring balloons. Since the brain stem directly controls the motor function of the esophagus, LEC was postulated to reflect the anesthetic state of the patient. Multiple-center clinical studies have shown that LEC correlates significantly with administered levels of intravenous and inhalation anesthetic agents and patient responses to surgical stimulation. Monitoring LEC permits the clinician to administer the dose of drug needed without the complications associated with "too deep" or "too light" anesthesia. 相似文献
10.
Dohle GR; Ramos L; Pieters MH; Braat DD; Weber RF 《Human reproduction (Oxford, England)》1998,13(3):620-623
Male genital tract obstructions may result from infections, previous
inguinal and scrotal surgery (vasectomy) and congenital bilateral absence
of the vas deferens (CBAVD). Microsurgery can sometimes be successful in
treating the obstruction. In other cases and in cases of failed surgical
intervention, the patient can be treated by microsurgical or percutaneous
epididymal sperm aspiration (MESA, PESA) or testicular sperm extraction
(TESE) and intracytoplasmic sperm injection (ICSI). We present the results
of 39 ICSI procedures for obstructive azoospermia in 24 couples. The
aetiology of the obstruction was failed microsurgery in 11 patients, CBAVD
in nine and genital infections in four. Sperm retrieval was accomplished
via MESA in four cases, PESA in 18 cases and via TESE in 11 cases. TESE was
only applied when PESA failed to produce enough spermatozoa for
simultaneous ICSI. In six patients, the ICSI procedure was performed with
cryopreserved spermatozoa after an initial PESA procedure. Fertilization
occurred in 47% of the metaphase II oocytes; embryo transfer was performed
in 92% of procedures and resulted in a clinical pregnancy in 13/39
procedures. Ongoing pregnancy was achieved in 10/39 procedures. One
pregnancy was terminated early after prenatal investigation showed a
cytogenetic abnormality (47,XX+18, Edwards syndrome). The other nine
pregnancies resulted in the live birth of 10 children, without any
congenital abnormalities. Epididymal and testicular retrieved spermatozoa
were successfully used for ICSI to treat obstructive azoospermia, and
resulted in an ongoing pregnancy in 10 of 24 couples (41.6%) after 39 ICSI
procedures, a success rate of 25.6% per treatment cycle and of 27.7% per
embryo transfer.
相似文献